SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: CORRESP
Document Type: CORRESP
Date Filed: 2025-08-25
Accession Number: 0001213900-25-080079
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025080079/filename1.htm

Chunk 0 of 1
Word Count: 233
Character Count: 1519

Document Content:

BANCROFT CAPITAL, LLC

501 Office Center Drive, Suite 130

Fort Washington, PA 19034

August 25, 2025

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, DC 20549

Attention: Chris Edwards

Re: Synergy CHC Corp.

Registration Statement on Form S-1

File No. 333-289645

REQUEST FOR ACCELERATION OF EFFECTIVENESS

Requested Date: Monday, August 25, 2025

Requested Time:	4:30 p.m., Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 under
the Securities Act of 1933, as amended (the “Securities Act”), we, as representative of the underwriters of the proposed public
offering of shares of the common stock of Synergy CHC Corp. (the “Company”), hereby join the Company’s request that
the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 4:30 p.m., Eastern
Time, on August 25, 2025, or as soon thereafter as possible.

Pursuant to Rule 460 under the Securities Act,
we hereby advise that we will distribute as many copies of the proposed form of preliminary prospectus as appears to be reasonable to
secure adequate distribution of the preliminary prospectus.

The undersigned advises that it has complied
and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

Very truly yours,

BANCROFT CAPITAL, LLC

By:	/s/ Jason Diamond

Name:	Jason Diamond

Title:	Head of Investment Banking